ライフサイエンスコーパス: in vitro fertilization

1 inase A phosphorylation, sperm motility, and in vitro fertilization.

2 ion success of embryos transferred following in vitro fertilization.

3 c-Myc), this line can only be maintained by in vitro fertilization.

4 cause of infertility and negatively impacts in vitro fertilization.

5 ients were induced in the aged oocytes after in vitro fertilization.

6 were within the range observed with standard in vitro fertilization.

7 g a safe number of embryos to transfer after in vitro fertilization.

8 essing gametes in vitro and usually involves in vitro fertilization.

9 -limiting step for the success of native and in vitro fertilization.

10 development of new therapies associated with in vitro fertilization.

11 matching FF and serum from women undergoing in vitro fertilization.

12 eld from embryo transfer in association with in vitro fertilization.

13 o guide the timing of embryo transfer during in vitro fertilization.

14 production via intrauterine insemination and in vitro fertilization.

15 , or those that formed blastocysts following in vitro fertilization.

16 he efficiency of blastocyst production after in vitro fertilization.

17 plantation bovine embryos (n = 23) following in vitro fertilization.

18 7BL/6J and C57BL/6N, with the routine use of in vitro fertilization.

19 xpected in a noncancer population undergoing in vitro fertilization.

20 ty therapy, possibly decreasing the need for in vitro fertilization.

21 otes are considered an unwanted byproduct of in vitro fertilization.

22 tural pregnancy and pregnancy conceived from in vitro fertilization.

23 187, and elicited a concomitant reduction of in vitro fertilization.

24 evelop may improve the success and safety of in vitro fertilization.

25 te cleavage and blastocyst development after in-vitro fertilization.

26 companies in the United States do not cover in vitro fertilization, a few states mandate such covera

27 learning in selecting the optimal embryo for in vitro fertilization, a multicenter, randomized, doubl

28 sing fertilized human embryos is crucial for in vitro fertilization, a task being revolutionized by a

29 ising rates of risk factors such as obesity, in vitro fertilization and advanced maternal age, the in

30 Antibodies to CD9 and CD98 inhibited in vitro fertilization and binding of the ADAM 3 disinte

31 After in vitro fertilization and culture, 76% of the blastocys

32 otropins, and some oocytes are competent for in vitro fertilization and early embryogenesis.

33 ical insufficiency (CI) in women who undergo in vitro fertilization and embryo transfer (IVF-ET) base

34 After in vitro fertilization and embryo transfer, healthy prog

35 Back-cross animals were generated using in vitro fertilization and genome scans performed utiliz

36 The use of in vitro fertilization and intracytoplasmic sperm inject

37 ART procedures such as in vitro fertilization and intracytoplasmic sperm inject

38 ditions as well as survival of embryos after in vitro fertilization and of organs after transplantati

39 tuberculosis (TB) in an infant conceived by in vitro fertilization and review 22 additional infant-m

40 study teases apart these mechanisms by using in vitro fertilization and shows that susceptibility of

41 chemotherapy, she harvested her eggs through in vitro fertilization and subsequently used preimplanta

42 oved pregnancy rates in fresh cycles of IVF (in vitro fertilization) and ICSI (intracytoplasmic sperm

43 round the world, many couples have turned to in vitro fertilization as a viable solution to fertility

44 ntracytoplasmic sperm injection coupled with in-vitro fertilization, as well as refinements in micros

45 lo3(-/-) sperm exhibit some fertility within in vitro fertilization assays.

46 epsis associated with chorioamnionitis in an in vitro fertilization-assisted pregnancy.

47 on failure occurring in approximately 50% of in vitro fertilization attempts.

48 iated with Huntington's disease can, through in vitro fertilization, avoid passing it on to one's off

49 duced oocyte binding and are incompetent for in vitro fertilization, but they can still produce viabl

50 These proteins were phenotyped using porcine in vitro fertilization, cell imaging, proteomics, and th

51 fluorescence staining, impermissible in the in vitro fertilization clinic.

52 parallel-group trial was conducted across 14 in vitro fertilization clinics in Australia and Europe.

53 c sperm injection (ICSI) is a technique that in vitro fertilization clinics use to treat a myriad of

54 ty to improve implantation success rates for in vitro fertilization clinics.

55 we were therefore able to conduct controlled in vitro fertilization competitions while concurrently m

56 nsistent for two experimental repeats of the in vitro fertilization competitions.

57 ed after 13 embryo transfers (31% versus 53% in vitro fertilization controls).

58 ICSI was performed in a programmed in vitro fertilization cycle using fresh spermatozoa.

59 at required complete coverage performed more in vitro fertilization cycles than clinics in states tha

60 In in vitro fertilization cycles using autologous oocytes,

61 nd nonaggregate analysis using registries of in vitro fertilization cycles with oocyte or embryo dona

62 In this diagnostic study of in vitro fertilization cycles, a prediction tool was dev

63 By screening day-3 embryos during in vitro fertilization cycles, we identified an associat

64 is measured in human follicular fluid during in vitro fertilization cycles.

65 ate detection of segmental aneuploidies from in vitro fertilization embryo biopsies, the origin and c

66 d embryonic stem cells (nt-ESCs), as well as in vitro fertilization embryo-derived ESCs (IVF-ESCs).

67 infertile women of a similar age undergoing in vitro fertilization-embryo transfer (45.0 v 38.2; P =

68 Based on a retrospective analysis of 764 in vitro fertilization-embryo transfer cycles, 13 key fa

69 o sell a new service to patients considering in vitro fertilization: embryo selection based on polyge

70 PRSs) have been offered since 2019 to screen in vitro fertilization embryos for genetic liability to

71 During in vitro fertilization, embryos deemed clinically useles

72 Although in vitro fertilization experiments suggest that the maiz

73 chanisms among icefish species, we performed in vitro fertilization experiments using eggs from a fem

74 In addition, in vitro fertilization, F2 inheritance and cross-fosteri

75 ciated with a decreased risk of abortion and in vitro fertilization failure.

76 uploid, leading to spontaneous miscarriages, in vitro fertilization failures and, when viable, severe

77 ive associations between ALPP polymorphisms, in vitro fertilization failures, and miscarriages.

78 ho underwent dilation subsequently underwent in vitro fertilization for embryo transfer (IVF-ET) or i

79 mitted vertically to offspring obtained from in vitro fertilization in laboratory settings.

80 sights to improve sperm cryopreservation and in vitro fertilization in the domestic and wild felids a

81 sted in more than one child, couples without in-vitro fertilization insurance coverage and couples wi

82 ly conceived fetuses and fetuses produced by in vitro fertilization, intracytoplasmic sperm injection

83 ng preimplantation culture, embryo transfer, in vitro fertilization, intracytoplasmic sperm injection

84 Deep learning in in vitro fertilization is currently being evaluated in t

85 In vitro fertilization is typically associated with high

86 The corresponding odds ratios with in vitro fertilization (IVF) (165 birth defects, 7.2%) w

87 ho conceived unassisted (comparison 1) or by in vitro fertilization (IVF) (comparison 2).

88 Expanding in vitro fertilization (IVF) access requires improved pa

89 In vitro fertilization (IVF) affects human fertility by

90 erved human embryos that were created during in vitro fertilization (IVF) and are in excess of clinic

91 3 weeks thereafter used as oocyte donors for in vitro fertilization (IVF) and as recipients for embry

92 ation of gene knockout NRG mice by combining in vitro fertilization (IVF) and CRISPR/Cas9 technology.

93 uman infertility have been overcome by using in vitro fertilization (IVF) and embryo transfer (ET) te

94 evice as highly suitable for applications in in vitro fertilization (IVF) and intracytoplasmic sperm

95 eggs following parthenogenetic activation or in vitro fertilization (IVF) and tracked their developme

96 Male-female couples who underwent in vitro fertilization (IVF) and/or intrauterine insemin

97 ormally at 2-cell mouse embryos generated by in vitro fertilization (IVF) but not SCNT.

98 assist fertility care providers in managing in vitro fertilization (IVF) cycles, these attempts fail

99 ovulation or for ovarian stimulation during in vitro fertilization (IVF) cycles.

100 OW insert that can be paired with a standard in vitro fertilization (IVF) dish to create WOW dishes w

101 The majority of embryos created through in vitro fertilization (IVF) do not implant.

102 degree of mosaic aneuploidy in healthy human in vitro fertilization (IVF) embryos.

103 C-based preimplantation genomic screening in in vitro fertilization (IVF) enables accurate and cost-e

104 In vitro fertilization (IVF) faces challenges in evaluat

105 to pregnancy loss, congenital anomalies, and in vitro fertilization (IVF) failure in humans.

106 s the primary cause of early miscarriage and in vitro fertilization (IVF) failure.

107 Although contemporary practice in in vitro fertilization (IVF) favors embryo transfer at b

108 and spontaneous abortion in women undergoing in vitro fertilization (IVF) from 1994 to 2003.

109 e national multiple birth rates, and data on in vitro fertilization (IVF) from 1997 through 2011 were

110 The prevalence of oocyte donation for in vitro fertilization (IVF) has increased in the United

111 In vitro fertilization (IVF) has resulted in the birth o

112 It is unclear whether weight loss before in vitro fertilization (IVF) improves reproductive outco

113 vious or ongoing medication with hormones or in vitro fertilization (IVF) in relation to the disease

114 rofiles in E18.5 mouse concepti generated by in vitro fertilization (IVF) in two different genetic ba

115 ase in estrogen levels, safety of performing in vitro fertilization (IVF) in women with breast cancer

116 Embryo assessment in in vitro fertilization (IVF) involves multiple tasks-inc

117 Although in vitro fertilization (IVF) is associated with adverse

118 In vitro fertilization (IVF) is associated with DNA meth

119 in vitro fertilization (IVF) is one of the most highly p

120 In vitro fertilization (IVF) is the most common assisted

121 In vitro fertilization (IVF) is the most widely used tec

122 lihood of achieving a live birth with repeat in vitro fertilization (IVF) is unclear, yet treatment i

123 We refined ovarian stimulation and in vitro fertilization (IVF) methods established for Chi

124 Infertility affects one in six couples, with in vitro fertilization (IVF) offering many the chance of

125 maximize birth rates, physicians who perform in vitro fertilization (IVF) often transfer multiple emb

126 e recourse to assisted reproduction, usually in vitro fertilization (IVF) or donor insemination (DI),

127 rpose, data from 1931 patients consisting of in vitro fertilization (IVF) or intra cytoplasmic sperm

128 ) or intrauterine insemination (IUI), or (4) in vitro fertilization (IVF) or intracytoplasmic sperm i

129 eproductive therapy (ART) couples treated by in vitro fertilization (IVF) or intracytoplasmic sperm i

130 iation of urinary phthalate metabolites with in vitro fertilization (IVF) outcomes, accounting for mu

131 ormula: see text]), and black carbon (BC) on in vitro fertilization (IVF) outcomes.

132 ver the allele encoding arginine (R72) among in vitro fertilization (IVF) patients.

133 preimplantation genetic diagnosis (PGD) and in vitro fertilization (IVF) performed for the preventio

134 This study investigates changes in in vitro fertilization (IVF) rates among health plan enr

135 Despite its high cost, the success rate for in vitro fertilization (IVF) remains < 33% in humans, dr

136 ly transduced mouse spermatozoa were used in in vitro fertilization (IVF) studies, and when followed

137 rom the mated female uterus partially rescue in vitro fertilization (IVF) that failed with epididymal

138 gnosis (PGD) to select an embryo produced by in vitro fertilization (IVF) that was unaffected by FA a

139 oidy (PGT-A) has become a routine add-on for in vitro fertilization (IVF) to determine whether human

140 on (ICSI) was initially developed as part of in vitro fertilization (IVF) to treat male-factor infert

141 ntrations of PFR metabolites and outcomes of in vitro fertilization (IVF) treatment among couples rec

142 Outcomes of in vitro fertilization (IVF) treatment are traditionally

143 Previous studies of breast cancer risk after in vitro fertilization (IVF) treatment were inconclusive

144 hysiological trigger of oocyte maturation in in vitro fertilization (IVF) treatment.

145 Nearly 75% of in vitro fertilization (IVF) treatments do not result in

146 roximately 5 million infants were born after in vitro fertilization (IVF) treatments.

147 standing infertility who is about to undergo in vitro fertilization (IVF) using donor oocytes from an

148 To address this question, we used in vitro fertilization (IVF) with a mutant and wild-type

149 sented 13 days after an oocyte retrieval for in vitro fertilization (IVF) with a positive home pregna

150 on in cleavage-stage embryogenesis following in vitro fertilization (IVF)(1-3), its rate in naturally

151 When semen was used for in vitro fertilization (IVF), 10% of embryos were transg

152 Before 8 h of in vitro fertilization (IVF), a mechanism exists that in

153 ividual ART procedures: hormone stimulation, in vitro fertilization (IVF), embryo culture and embryo

154 gestation is one of the biggest risks after in vitro fertilization (IVF), largely due to multiple em

155 by site and intended infertility treatment (in vitro fertilization (IVF), non-IVF/study site, and no

156 t, treatment with intrauterine insemination, in vitro fertilization (IVF), or intracytoplasmic sperm

157 In in vitro fertilization (IVF), progesterone is often adde

158 of intracytoplasmic sperm injection (ICSI), in vitro fertilization (IVF), sperm removal, reinjection

159 The suLe(X)-coverslip was adapted for in vitro fertilization (IVF), termed glycan-IVF, by allo

160 For in vitro fertilization (IVF), the program mandated an el

161 uality in animal models and women undergoing in vitro fertilization (IVF), we consider it an ovarian

162 By examining a large set of zygotes from in vitro fertilization (IVF), we find that success in pr

163 oplasmic sperm injection (ICSI) and standard in vitro fertilization (IVF), we found that Ca(2+) influ

164 chromosome mosaicism observed in studies of in vitro fertilization (IVF)-derived human preimplantati

165 sociation of COVID-19 vaccination status and in vitro fertilization (IVF)-fresh embryo transfer cycle

166 totoxic and thus is not allowed during human in vitro fertilization (IVF).

167 ted or related to their child as a result of in vitro fertilization (IVF).

168 ulture that markedly improved the outcome of in vitro fertilization (IVF).

169 ess beyond the two pronuclei stage following in vitro fertilization (IVF).

170 sisted conceptions and those conceived using in vitro fertilization (IVF).

171 comes, is increasingly related to the use of in vitro fertilization (IVF).

172 probability of pregnancy in women undergoing in vitro fertilization (IVF).

173 n eggs and preimplantation embryos following in vitro fertilization (IVF).

174 interest in using PES if already undergoing in vitro fertilization (IVF).

175 pregnancy loss, including in the context of in vitro fertilization (IVF).

176 allow specific selection of sperm cells for in vitro fertilization (IVF).

177 reproductive outcome in patients undergoing in vitro fertilization (IVF).

178 nd obese infertile women who were undergoing in vitro fertilization (IVF).

179 lear evidence of a benefit over conventional in vitro fertilization (IVF).

180 implantation failure among women undergoing in vitro fertilization (IVF).

181 o the woman of human embryos created through in vitro fertilization (IVF).

182 ne allele is enriched in patients undergoing in vitro fertilization (IVF).

183 c sperm injection (ICSI) versus conventional in vitro fertilization (IVF); and frozen-thawed versus f

184 time of oocyte retrieval who were undergoing in vitro fertilization (IVF); miRNA levels were determin

185 icting success for a first autologous oocyte in-vitro fertilization (IVF) cycle.

186 l, we randomly assigned 992 women undergoing in-vitro fertilization (IVF) with a good prognosis (aged

187 Reproductive management using in-vitro fertilization (IVF) with cryopreserved sperm ha

188 anced maternal age and increased reliance on in vitro fertilization, means that an increasing subset

189 s from mother to child is now a reality with in vitro fertilization mitochondrial replacement techniq

190 r intrauterine insemination (n = 24,962) and in-vitro fertilization (n = 22,666), in which 2,458 (5.3

191 948]) and assisted reproductive technology (in vitro fertilization [n = 19 448], intracytoplasmic sp

192 These were produced by in vitro fertilization of Bos taurus taurus oocytes with

193 inhibits the binding of sperm to eggs during in vitro fertilization of ZP-free eggs.

194 Given the success of in vitro fertilization, one would think that the mechani

195 Type of fertilization (standard in vitro fertilization or intracytoplasmic sperm injecti

196 y and 1,008 whose conception was assisted by in vitro fertilization or intrauterine insemination and

197 f clinical pregnancy or live birth following in vitro fertilization or intrauterine insemination.

198 ied live-birth pregnancies conceived through in-vitro fertilization or intrauterine insemination.

199 njected, blocks second polar body formation, in vitro fertilization, or cytokinesis.

200 dy center and planned infertility treatment (in vitro fertilization, other treatment at a study site,

201 s cryopreserved embryos pose a challenge for in vitro fertilization patients and clinics; with Roe v.

202 cing through characterization of in vivo and in vitro fertilization phenotypes, including insights fr

203 s a clinical indicator of male fertility and in vitro fertilization potential: chromosome aneuploidy

204 surplus embryos illegal, radically changing in vitro fertilization practice.

205 Participants underwent in vitro fertilization, preimplantation genetic testing

206 component of the capacitation medium used in in vitro fertilization procedures in mammals.

207 asm, leading to decreased sperm motility and in vitro fertilization rates.

208 In vitro fertilization-related and other experiments rev

209 Transgenic boar fertility was confirmed by in vitro fertilization, resulting in transgenic blastocy

210 reproductive outcomes among women undergoing in vitro fertilization: results from the EARTH study.

211 ata to determine utilization and outcomes of in vitro fertilization services according to the status

212 State-mandated insurance coverage for in vitro fertilization services is associated with incre

213 Of the states in which in vitro fertilization services were available, 3 states

214 ted in recombinant fertilin beta-EC prior to in vitro fertilization show reduced levels of sperm bind

215 hat undergo AE, and live-cell imaging during in vitro fertilization showed that the midpiece contract

216 option-at-birth study), and the Cardiff IVF (In Vitro Fertilization) Study (an adoption-at-conception

217 This suggests that research on improving in vitro fertilization success rates should move from it

218 at interest--particularly with the advent of in vitro fertilization techniques for treating male infe

219 Recent advances in in vitro fertilization techniques, have greatly improved

220 ill be amenable to development of successful in vitro fertilization techniques.

221 uce ovarian stimulation for both in vivo and in vitro fertilization therapy.

222 ration in women with subfertility undergoing in vitro fertilization therapy.

223 o trigger egg maturation in women undergoing in vitro fertilization therapy.

224 sts containing aneuploid cells are worthy of in vitro fertilization transfer.

225 ects one-in-six couples, often necessitating in vitro fertilization treatment (IVF).

226 Prospective 6.5-year follow-up and in vitro fertilization treatment data revealed distinct

227 icant after controlling for age, work hours, in vitro fertilization use, and multiple gestation (odds

228 t established method and the success rate of in-vitro fertilization using frozen-thawed embryos now a

229 omeres removed from 8-cell embryos following in vitro fertilization was analyzed for HLA genes simult

230 In vitro fertilization was compromised, especially at ea

231 In vitro fertilization was performed using ASMKO(+/-) oo

232 The extent of in vitro fertilization was reduced in a dose-dependent m

233 udy, in three independent couples undergoing in vitro fertilization, we first identified male gonadal

234 Using in vitro fertilization, we have rescued and characterize

235 d fertilization from 107 patients undergoing in vitro fertilization were analyzed by FISH using X-, 1

236 ones on muscle function, patients undergoing in vitro fertilization were tested during two phases of

237 M can potentially become a valuable tool for in vitro fertilization, where contrast agents and fluoro

238 lly the stromal cells, from women undergoing in vitro fertilization who failed to achieve pregnancy.

239 of both recmSLLP1 and antibodies to SLLP1 on in vitro fertilization with both cumulus intact and zona

240 In vitro fertilization with or without intracytoplasmic

241 cluding intrauterine insemination cycles and in vitro fertilization with or without intracytoplasmic

242 e cell manipulation system commonly used for in vitro fertilization with the Single-probe SCMS sampli

243 In vitro fertilization, with a cycle defined as an episo

244 M process involves embryo generation through in vitro fertilization, with subsequent testing of embry

245 y assisted reproductive technologies such as in vitro fertilization, yet pregnancy success rates usin

246 Among patients for whom in vitro fertilization yielded a euploid blastocyst, the